These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22422099)

  • 21. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
    Valk PE; Mathis CA; Prados MD; Gilbert JC; Budinger TF
    J Nucl Med; 1992 Dec; 33(12):2133-7. PubMed ID: 1334136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
    Jeong SY; Lim SM
    Nucl Med Biol; 2012 Oct; 39(7):977-81. PubMed ID: 22483845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
    Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
    No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the Prognostic Value of Radiomic Features in
    Muzi M; Wolsztynski E; Fink JR; O'Sullivan JN; O'Sullivan F; Krohn KA; Mankoff DA
    Tomography; 2020 Mar; 6(1):14-22. PubMed ID: 32280746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.
    Toyonaga T; Hirata K; Yamaguchi S; Hatanaka KC; Yuzawa S; Manabe O; Kobayashi K; Watanabe S; Shiga T; Terasaka S; Kobayashi H; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1469-76. PubMed ID: 26841941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET.
    Rockne RC; Trister AD; Jacobs J; Hawkins-Daarud AJ; Neal ML; Hendrickson K; Mrugala MM; Rockhill JK; Kinahan P; Krohn KA; Swanson KR
    J R Soc Interface; 2015 Feb; 12(103):. PubMed ID: 25540239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas.
    Yamamoto Y; Ono Y; Aga F; Kawai N; Kudomi N; Nishiyama Y
    J Nucl Med; 2012 Dec; 53(12):1911-5. PubMed ID: 23081994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO).
    Tochon-Danguy HJ; Sachinidis JI; Chan F; Chan JG; Hall C; Cher L; Stylli S; Hill J; Kaye A; Scott AM
    Nucl Med Biol; 2002 Feb; 29(2):191-7. PubMed ID: 11823124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography.
    Lawrentschuk N; Poon AM; Foo SS; Putra LG; Murone C; Davis ID; Bolton DM; Scott AM
    BJU Int; 2005 Sep; 96(4):540-6. PubMed ID: 16104907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
    Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer.
    Thorwarth D; Eschmann SM; Scheiderbauer J; Paulsen F; Alber M
    BMC Cancer; 2005 Dec; 5():152. PubMed ID: 16321146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
    Chen L; Zhang Z; Kolb HC; Walsh JC; Zhang J; Guan Y
    Nucl Med Commun; 2012 Oct; 33(10):1096-102. PubMed ID: 22836736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma.
    Mapelli P; Picchio M
    Int J Biol Markers; 2020 Feb; 35(1_suppl):42-46. PubMed ID: 32079461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratumoral heterogeneity of
    Mitamura K; Yamamoto Y; Kudomi N; Maeda Y; Norikane T; Miyake K; Nishiyama Y
    Ann Nucl Med; 2017 Jan; 31(1):46-52. PubMed ID: 27686469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
    O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
    Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.